Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
Clinical trial NCT01515189 · COMPLETED
Trial details
- NCT number
- NCT01515189
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-17
- Primary completion
- 2016-02-06
- Enrollment
- 831
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.